Changes in glucosylceramide structure affect virulence and membrane biophysical properties of Cryptococcus neoformans

This publication has 49 references indexed in Scilit:

• Methylation of glycosylated sphingolipid modulates membrane lipid topography and pathogenicity of Cryptococcus neoformans
  Cellular Microbiology, 2011
• Measurement of Lipid Nanodomain (Raft) Formation and Size in Sphingomyelin/POPC/Cholesterol Vesicles Shows TX-100 and Transmembrane Helices Increase Domain Size by Coalescing Preexisting Nanodomains But Do Not Induce Domain Formation
  Biophysical Journal, 2011
• Catch me if you can: phagocytosis and killing avoidance by Cryptococcus neoformans
  FEMS Immunology & Medical Microbiology, 2011
• Surface Localization of Glucosylceramide during Cryptococcus neoformans Infection Allows Targeting as a Potential Antifungal
  PLOS ONE, 2011
• Evidence of a Role for Monocytes in Dissemination and Brain Invasion byCryptococcus neoformans
  Infection and Immunity, 2009
• Depletion of Alveolar Macrophages Decreases the Dissemination of a Glucosylceramide-Deficient Mutant ofCryptococcus neoformansin Immunodeficient Mice
  Infection and Immunity, 2007
• The Cryptococcal Enzyme Inositol Phosphosphingolipid-Phospholipase C Confers Resistance to the Antifungal Effects of Macrophages and Promotes Fungal Dissemination to the Central Nervous System
  Infection and Immunity, 2006
• Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans
  Journal of Clinical Investigation, 2006
• Disruption of the glucosylceramide biosynthetic pathway in Aspergillus nidulans and Aspergillus fumigatus by inhibitors of UDP‐Glc:ceramide glucosyltransferase strongly affects spore germination, cell cycle, and hyphal growth
  FEBS Letters, 2002
• A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
  Canadian Journal of Biochemistry and Physiology, 1959